Clinical trial
A Multicenter, Two Arm, Randomized, Open Label Clinical Study Investigating Renal Function in an Advagraf® Based Immunosuppressive Regimen With or Without Sirolimus in Kidney Transplant Patients
NCT01363752 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Two Arm, Randomized, Open Label Clinical Study Investigating Renal Function in an Advagraf® Based Immunosuppressive Regimen With or Without Sirolimus in Kidney Transplant Patients
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 8, 2011
- Completion date
- September 18, 2013
- Enrollment
- 853 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplantation